BELOVA Data Collection: Safety and Efficacy of Frontline Bevacizumab Treatment in Participants With Ovarian Cancer 70 Years and Older
- Status
- COMPLETED
- Phase
- N/A
Clinical Trials Related to Ovarian Cancer
Related studies linked through entity extraction aliases.
A Study of CRLX101(NLG207) in Combination With Weekly Paclitaxel in Patients With Recurrent or Persistent Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Phase 1b Safety Study of CMB305 in Patients With Locally Advanced, Relapsed, or Metastatic Cancer Expressing NY-ESO-1
- Status
- TERMINATED
- Phase
- PHASE1
Paclitaxel/Pazopanib for Platinum Resistant/Refractory Ovarian Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Salpingectomy at Cesarean Delivery for Ovarian Cancer Reduction (SCORE)
- Status
- COMPLETED
- Phase
- NA
Psychosexual Consequences of Risk-reducing Salpingo-oophorectomy
- Status
- COMPLETED
- Phase
- NA
Alisertib (MLN8237) in Combination With Weekly Paclitaxel in East Asian Patients With Advanced Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1
A Study of Niraparib in Patients With Ovarian Cancer Who Have Received Three or Four Previous Chemotherapy Regimens
- Status
- COMPLETED
- Phase
- PHASE2
Niraparib Versus Niraparib-bevacizumab Combination in Women With Platinum-sensitive Epithelial Ovarian Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Hula, a Physical Activity Intervention for Female-Cancer Survivors
- Status
- COMPLETED
- Phase
- NA
Clinical Trial of Intraperitoneal Hyperthermic Chemotherapy
- Status
- UNKNOWN
- Phase
- PHASE2
Study of CM-24 (MK-6018) Alone and In Combination With Pembrolizumab (MK-3475) in Participants With Selected Advanced or Recurrent Malignancies (MK-6018-001)
- Status
- TERMINATED
- Phase
- PHASE1
A Trial of Vigil for Participants With Ovarian Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Capturing BRCA1/2 Mutational Status in Women With High Grade Serous Ovarian Cancer and Impact on Clinical Outcome.
- Status
- TERMINATED
- Phase
- N/A
A Study of Cediranib and Olaparib at the Time Ovarian Cancer Worsens on Olaparib
- Status
- COMPLETED
- Phase
- PHASE2
A Study of the Safety, Tolerability, and Efficacy of Epacadostat Administered in Combination With Nivolumab in Select Advanced Cancers (ECHO-204)
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
BMN 673 (Talazoparib), an Oral PARP Inhibitor, in People With Deleterious BRCA1/2 Mutation-Associated Ovarian Cancer Who Have Had Prior PARP Inhibitor Treatment
- Status
- TERMINATED
- Phase
- PHASE2
Prospective Multicenter Study in Patients With a Tumor Benign Ovarian Presumed on the Use of Algorithms Such as Roma and RMI and Tumor Markers Such as CA125 and HE4
- Status
- COMPLETED
- Phase
- N/A
DOD Long-Term Survivors of Ovarian Cancer
- Status
- UNKNOWN
- Phase
- NA
Early Salpingectomy (Tubectomy) With Delayed Oophorectomy in BRCA1/2 Gene Mutation Carriers
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- NA